Novartis Amneal Deal Would Do Little for Drugmaker's Pipeline

Bookmark
(Bloomberg Gadfly) -- Novartis AG seems to have a growing appetite for M&A and is developing some new tastes along the way.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.